An International, Multicentre, Efficacy and Safety Study of I10E in Initial and Maintenance Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Phase of Trial: Phase III
Latest Information Update: 30 Nov 2017
At a glance
- Drugs Immune globulin (Primary)
- Indications Chronic inflammatory demyelinating polyradiculoneuropathy
- Focus Registrational; Therapeutic Use
- Acronyms PRISM
- Sponsors LFB Biotechnologies
- 27 Nov 2017 Status changed from recruiting to completed.
- 25 Oct 2017 The trial has been completed in Spain.
- 02 Aug 2017 The trial has been completed in Germany.